These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing next-generation offerings.

Blockbuster weight loss drugs like Ozempic, Wegovy and Mounjaro might not work as well as advertised, a bombshell study from ...

According to the article, that investor aims to influence the company's choice of a chief executive.

GLP-1 meds may help — or harm — those with bipolar disorder. Read firsthand accounts of mood changes, weight loss, and side ...

A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups.

A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups. Despite the trend, local health experts advise caution, highlighting the ...

While Americans understand the benefits of GLP-1 agonist medications, 83% of Americans are unwilling to pay more than $100 in ...

CVS Caremark identified GLP-1 drugs and Humira as points of contention, but the State Health Plan says that mischaracterizes ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

By triggering weight loss using the likes of Ozempic, people can expect various possible changes to their appearance ...

Why Might Some People Opt to Take an Oral Version of Wegovy Instead of Injections? There are multiple reasons why someone ...

Jack Daniel's is losing ground as Americans turn to cannabis, weight-loss drugs, and Gen Z snubs liquor. Discover why whiskey ...